11.45-13.15     HALL F

Uremic cardiomyopathy

Chairs: Kamyar Kalantar-Zadeh, Irvine, U.S.A.
             Roland E. Schmieder, Erlangen, Germany

Thick but weak: the pathophysiology of uremic cardiomyopathy
Kerstin Amann, Erlangen, Germany
Non-invasive assessment of cardiac structure and function - what nephrologists must know
Frank Flachskampf, Uppsala, Sweden
Clinical consequences: cardiac arrhythmia and SCD
Philip A. Kalra, Salford, United Kingdom
Future perspectives in the treatment of uremic cardiomyopathy
Marc Vervloet, Amsterdam, The Netherlands


back to the timetable

final programme "day by day" - may 21 - 24, 2016